Trial Profile

Molecular profiling of post-menopausal women with breast cancer on neoadjuvant endocrine therapy with tamoxifen or exemestane.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 12 Oct 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Exemestane (Primary) ; Tamoxifen (Primary)
Indications Breast cancer
Focus Biomarker; Therapeutic Use
Acronyms MoNET

Most Recent Events

24 Feb 2011 Planned end date changed from 1 Jan 2010 to 1 May 2011 as reported by ISRCTN: Current Controlled Trials.
22 Feb 2011 Status changed from recruiting to completed, as reported by Current Controlled Trials.
20 Apr 2007 New trial record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com